FORT WORTH, Texas, Sept. 5 /PRNewswire-FirstCall/ -- Wound Care
Innovations, LLC, a subsidiary of Wound Management Technologies, Inc.,
(OTC Bulletin Board: WNDM), announced today that Cathy Bradshaw, President,
was interviewed by the Zangani Investor Community on their advanced wound care
collagen product, CellerateRx(R). Ms. Bradshaw briefly discussed some of the
recent announcements of the company, distinguishing unique product
characteristics and plans for international distribution. "It was a pleasure
to be interviewed by the Zangani Investor Community," states Cathy Bradshaw.
"We are excited about the recent agreement with Dr. Shapiro, the publication
of the case reports in Advances in Skin & Wound Care, as well as the other
recent announcements. These will enable us to increase revenues through
additional sales and other distribution arrangements which the company has in
the works."
The entire interview is available at:
http://www.zangani.com/webcasts/20080903/woundcare
www.zangani.com - Available Online and via Podcast.
About Wound Management Technologies, Inc.:
Wound Management Technologies, Inc. (OTCBB: WNDM), with its corporate
headquarters in Fort Worth, Texas, markets and distributes wound care products
to the healthcare market under patented technology licensed to the Company.
The Company is positioned and seeks to be a leading provider of wound care
products. For more information on the Company please visit the Company's
Website at www.Celleraterx.com .
"Safe Harbor" Statement: Under The Private Securities Litigation Reform
Act of 1995: The statements in the press release that relate to the company's
expectations with regard to the future impact on the company's results from
new products in development are "forward-looking statements," within the
meaning of the Private Securities Litigation Reform Act of 1995. Since this
information may contain statements that involve risk and uncertainties and are
subject to change at any time, the company's actual results may differ
materially from expected results. This document may contain forward-looking
statements concerning the Company's operations, current and future performance
and financial condition. These items involve risks and uncertainties such as
product demand, market and customer acceptance, the effect of economic
conditions, competition, pricing, the ability to consummate and integrate
acquisitions, and other risks and uncertainties detailed in the Company's SEC
filings. The Company undertakes no obligation to revise any of these
statements to reflect the future circumstances or the occurrence of
unanticipated events.
For Further Information:
Product Information Shareholder Relations
Cathy Bradshaw Lucy Singleton
President Secretary
954-315-9242 817-820-7080
SOURCE Wound Management Technologies, Inc.
